Myomo (MYO) Non Operating Income (2016 - 2025)
Myomo (MYO) posted Non Operating Income of -$9743.0 for Q3 2025, down 109.14% on a QoQ basis from $106549.0 in Q2 2025, and down 112.82% year-over-year from $76020.0 in Q3 2024.
Myomo (MYO) Non Operating Income (2016 - 2025) Analysis & Trends
Myomo's Non Operating Income history runs 10 years deep, the most recent figure standing at -$9743.0 for Q3 2025.
- Quarterly Non Operating Income fell 112.82% year-over-year to -$9743.0 in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $358828.0 (down 15.92% YoY) and the FY2024 annual result came in at $388586.0, down 5.29% from the prior year.
- Non Operating Income was -$9743.0 for Q3 2025 at Myomo, down from $106549.0 in the prior quarter.
- Across five years, Non Operating Income topped out at $191991.0 in Q1 2025 and bottomed at -$9743.0 in Q3 2025.
- A 5-year average of $62000.1 and a median of $70031.0 in 2024 frame the typical range for Non Operating Income.
- Annual changes were most pronounced in 2021 — Non Operating Income tumbled 113.56% — and 2023, when it jumped 47852.22%.
- Myomo's Non Operating Income stood at $11805.0 in 2021, then surged by 245.18% to $40748.0 in 2022, then surged by 165.59% to $108221.0 in 2023, then tumbled by 35.29% to $70031.0 in 2024, then slumped by 113.91% to -$9743.0 in 2025.
- Business Quant data shows MYO's Non Operating Income at -$9743.0 in Q3 2025, $106549.0 in Q2 2025, and $191991.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 62.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | -18.60 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | - |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | - |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | - |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Myomo | 39.24 Mn | 20.27 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -9,743.00 |
| Jun 30, 2025 | 106,549.00 |
| Mar 31, 2025 | 191,991.00 |
| Dec 31, 2024 | 70,031.00 |
| Sep 30, 2024 | 76,020.00 |
| Jun 30, 2024 | 107,242.00 |
| Mar 31, 2024 | 135,293.00 |
| Dec 31, 2023 | 108,221.00 |
| Sep 30, 2023 | 112,300.00 |
| Jun 30, 2023 | 103,439.00 |
| Mar 31, 2023 | 86,314.00 |
| Dec 31, 2022 | 40,748.00 |
| Sep 30, 2022 | 33,958.00 |
| Jun 30, 2022 | 13,845.00 |
| Mar 31, 2022 | 180.00 |
| Dec 31, 2021 | 11,805.00 |
| Sep 30, 2021 | -4,055.00 |
| Jun 30, 2021 | -6,018.00 |
| Mar 31, 2021 | -119.00 |
| Dec 31, 2020 | 1,867.00 |